71 results
Page 3 of 4
8-K
EX-10.1
pqhzmq
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
r58x7luq6ayq2t 5l
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
m0xfs
14 May 21
Quarterly report
4:31pm
10-K
EX-10.1
mzk1k16ln4d1
31 Mar 21
Annual report
4:30pm
10-K
EX-4.4
9wa zyfmx7fq
31 Mar 21
Annual report
4:30pm
10-K
EX-10.9
5bq6mcfa n6h1kqo
31 Mar 21
Annual report
4:30pm
10-K
z4rthtzs3ufpe5d pu
31 Mar 21
Annual report
4:30pm
8-K
h618v8ltuyivyajcen
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
mu1m8ptth20f i1
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
eb0aw7c6pf8s
29 Jan 21
Shelf registration
4:48pm
S-8
5zap 3ex0pr
22 Jan 21
Registration of securities for employees
4:15pm
8-K/A
EX-10.1
7kcssys
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.1
8tkq9 jhhgky0
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.2
gnvbksrnulb8e lv
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
4o91f
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
8-K
EX-10.1
pmaz87qm4x 37xi
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
b2mvza b7
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.2
ap21np0ul ml3oi7q292
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.1
ewcam91kr0r6u
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am